Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2621 – 2640 of 3231

Table 1. Primary Prophylaxis

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/primary-prophylaxis-full

Antiretroviral Treatment Regimens Recommended for Initial Therapy in Infants and Children With HIV

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/regimens-recommended-initial-therapy-antiretroviral-naive-children

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/emtricitabine

Mycobacterium tuberculosis Infection and Disease

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/mycobacterium

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/panel-roster

Special Populations: Adolescents and Young Adults With HIV

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/special-populations-adolescents-young-adults

Table 3. Treatment

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-3-treatment

Antiretroviral Treatment Interruption in Children With HIV

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/antiretroviral-treatment-interruption-children-hiv

https://clinicalinfo.hiv.gov/guidelines/perinatal/introduction

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/introduction

Initiation of Antiretroviral Therapy

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/initiation-antiretroviral-therapy

Herpes Simplex Virus

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/herpes-simplex

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/cobicistat

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/enfuvirtide

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/cryptococcosis

What's New in the Guidelines

https://clinicalinfo.hiv.gov/guidelines/perinatal/whats-new

Zidovudine (Retrovir, ZDV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-zidovudine-retrovir

Osteopenia and Osteoporosis

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/osteopenia-and-osteoporosis

Antiretroviral Drug Resistance and Resistance Testing in Pregnancy

https://clinicalinfo.hiv.gov/guidelines/perinatal/antepartum-care-arv-drug-resistance-testing

Tenofovir Disoproxil Fumarate (Viread, TDF)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-nrtis-tenofovir-disoproxil-fumarate-viread